Sonic Healthcare Limited (ASX:SHL) agreed to acquire Dr. Risch Shared Services Ag for CHF 117 million on March 20, 2024. The purchase price will include the issue to the sellers with minimum number of Sonic ordinary shares that are to be issued is 1,839,397, with the balance to be funded in Swiss francs from Sonic?s existing cash and debt facilities. In CY 2023 the Swiss laboratories generated revenue of CHF 94 million, with a further CHF 8 million of revenue generated by the laboratory in Liechtenstein.

The integration of Dr Risch with Sonic?s existing Swiss operations, including the recently acquired Synlab Suisse laboratories, will be led by Sonic?s existing Swiss leadership team together with Dr Risch?s management team, which will continue with Sonic into the future. The transaction is expected to close by 31 March 2024.